Furthermore, both the NK-mediated as well as TCR-mediated cytotoxicity of the NK:TCR cells is enhanced, resulting in improved persistence and performance of NK:TCR/IL-15 cells in an orthotopic multiple myeloma mouse model. The gene discussed is IL15; the disease is plasma cell myeloma.